Scarica l'app Stockscreener
3.09
3.34%
0.10
Pre-mercato:
3.13
0.04
+1.29%
Precedente Chiudi:
$2.99
Aprire:
$3
Volume 24 ore:
1.57M
Relative Volume:
0.44
Capitalizzazione di mercato:
$417.13M
Reddito:
-
Utile/perdita netta:
$-35.47M
Rapporto P/E:
-5.4211
EPS:
-0.57
Flusso di cassa netto:
$-124.27M
1 W Prestazione:
+4.39%
1M Prestazione:
+24.60%
6M Prestazione:
+317.57%
1 anno Prestazione:
+76.57%
Intervallo 1D:
$2.88
$3.18
Intervallo di 1 settimana:
$2.77
$3.47
Portata 52W:
$0.4603
$7.13
Prokidney Corp Stock (PROK) Company Profile
Nome
Prokidney Corp
Settore
Industria
Telefono
336-999-7028
Indirizzo
2000 FRONTIS PLAZA BLVD., WINSTON-SALEM
Confronta PROK con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
PROK
Prokidney Corp
|
3.09 | 403.63M | 0 | -35.47M | -124.27M | -0.57 |
|
VRTX
Vertex Pharmaceuticals Inc
|
412.22 | 104.45B | 11.39B | 3.64B | 3.50B | 13.99 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
469.36 | 60.95B | 2.46B | -319.09M | -52.09M | -2.4669 |
|
REGN
Regeneron Pharmaceuticals Inc
|
572.60 | 59.11B | 14.21B | 4.46B | 3.56B | 39.69 |
|
ARGX
Argen X Se Adr
|
812.95 | 49.23B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ONC
Beone Medicines Ltd Adr
|
320.94 | 35.92B | 4.56B | -176.77M | 225.30M | -1.7177 |
Prokidney Corp Stock (PROK) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-06-30 | Downgrade | BofA Securities | Neutral → Underperform |
| 2024-09-30 | Iniziato | JP Morgan | Neutral |
| 2024-09-10 | Iniziato | Guggenheim | Buy |
| 2024-03-07 | Ripresa | Morgan Stanley | Equal-Weight |
| 2024-01-02 | Downgrade | BofA Securities | Buy → Neutral |
| 2023-07-25 | Iniziato | BTIG Research | Buy |
| 2022-12-21 | Iniziato | Jefferies | Buy |
| 2022-11-10 | Iniziato | Morgan Stanley | Equal-Weight |
| 2022-10-18 | Iniziato | UBS | Buy |
| 2022-10-14 | Iniziato | Citigroup | Buy |
| 2022-09-23 | Iniziato | BofA Securities | Buy |
| 2022-09-02 | Iniziato | Evercore ISI | Outperform |
Mostra tutto
Prokidney Corp Borsa (PROK) Ultime notizie
Risk adjusted return profile for ProKidney Corp. analyzed2025 Buyback Activity & Weekly Stock Breakout Alerts - newser.com
Why ProKidney Corp. is moving today2025 Macro Impact & Weekly Momentum Stock Picks - newser.com
Heatmap analysis for ProKidney Corp. and competitorsMarket Weekly Review & Long-Term Safe Investment Plans - newser.com
Using AI based signals to follow ProKidney Corp.July 2025 Breakouts & Weekly High Return Opportunities - newser.com
Is ProKidney Corp. stock poised for growthBond Market & Technical Pattern Alert System - newser.com
How to monitor ProKidney Corp. with trend dashboardsQuarterly Profit Report & Safe Capital Preservation Plans - newser.com
Short interest data insights for ProKidney Corp.Layoff News & Community Consensus Stock Picks - newser.com
Price momentum metrics for ProKidney Corp. explainedWeekly Profit Summary & Consistent Income Trade Ideas - newser.com
Discovering Potential: IZEA Worldwide And 2 Other Top Penny Stocks - simplywall.st
ProKidney's (PROK) "Sell (D-)" Rating Reaffirmed at Weiss Ratings - MarketBeat
Why ProKidney Corp. stock appeals to dividend seekersJuly 2025 Earnings & Weekly Top Gainers Trade List - newser.com
Real time pattern detection on ProKidney Corp. stock2025 Winners & Losers & Fast Exit and Entry Strategy Plans - newser.com
ProKidney (NASDAQ:PROK) Shares Gap DownWhat's Next? - MarketBeat
Will ASN Spotlight On REGEN-007 Propel ProKidney Toward Accelerated Approval? - RTTNews
What institutional flow reveals about ProKidney Corp.Layoff News & Smart Allocation Stock Reports - newser.com
Smart tools for monitoring ProKidney Corp.’s price actionGap Up & Community Consensus Trade Alerts - newser.com
ProKidney Corp (PROK) Touts Reparencel Therapy for Growth - MSN
Will ProKidney Corp. see short term momentumJuly 2025 Trade Ideas & Safe Entry Point Alerts - newser.com
Is it time to cut losses on ProKidney Corp.2025 Institutional Moves & Consistent Profit Trade Alerts - newser.com
ProKidney (NASDAQ:PROK) Trading 8.1% HigherShould You Buy? - MarketBeat
What drives ProKidney Corp stock priceTop Performing Stocks & Create Your Free Watchlist Instantly - earlytimes.in
Is ProKidney Corp a good long term investmentRisk Management Strategies & Low Cost Market Strategies - earlytimes.in
ProKidney Corp. (NASDAQ:PROK) Given Consensus Recommendation of "Hold" by Analysts - MarketBeat
Layoff Watch: Is TBBB stock a top performer YTDGDP Growth & Weekly High Momentum Picks - khodrobank.com
ProKidney spikes after mid-stage trial data for lead asset - MSN
Earnings Beat: Is ProKidney Corp impacted by rising ratesWeekly Gains Report & Stepwise Trade Execution Plans - khodrobank.com
Whale Trades: What are ProKidney Corp.’s recent SEC filings showingGlobal Markets & Verified Entry Point Detection - خودرو بانک
ProKidney: Slow-Burning 'Buy' Opportunity Based On 2027 Approval Of Kidney Disease Therapy - Seeking Alpha
ETF Watch: Why is ProKidney Corp stock going downJuly 2025 Review & Community Driven Trade Alerts - خودرو بانک
Prokidney Corp Azioni (PROK) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
5.15%
1.45%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):